Matches in Wikidata for { <http://www.wikidata.org/entity/Q71931319> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q71931319 description "artículu científicu espublizáu n'avientu de 1996" @default.
- Q71931319 description "im Dezember 1996 veröffentlichter wissenschaftlicher Artikel" @default.
- Q71931319 description "scientific article published on 01 December 1996" @default.
- Q71931319 description "wetenschappelijk artikel" @default.
- Q71931319 description "наукова стаття, опублікована в грудні 1996" @default.
- Q71931319 name "Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen" @default.
- Q71931319 name "Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen" @default.
- Q71931319 type Item @default.
- Q71931319 label "Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen" @default.
- Q71931319 label "Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen" @default.
- Q71931319 prefLabel "Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen" @default.
- Q71931319 prefLabel "Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen" @default.
- Q71931319 P1433 Q71931319-F98BF6B2-0561-4BF8-BE56-151EDE2696D7 @default.
- Q71931319 P1476 Q71931319-DF94DDFA-1D06-4899-B492-B683FFB01A83 @default.
- Q71931319 P2093 Q71931319-159584B4-27C8-4FF4-A120-7EA22BE1D257 @default.
- Q71931319 P2093 Q71931319-2CB1D3FB-3209-46E0-8658-013B52D67102 @default.
- Q71931319 P2093 Q71931319-6751B231-46F7-4C87-A4DB-B266754F73F9 @default.
- Q71931319 P2093 Q71931319-91A215C3-0EC2-468D-8AC9-7E777FEDC90C @default.
- Q71931319 P2093 Q71931319-C97937FE-9784-4405-8062-5EA3666DDD08 @default.
- Q71931319 P304 Q71931319-F0B326F2-DF78-4DB1-8100-025633FA5792 @default.
- Q71931319 P31 Q71931319-6210AE98-62DD-4539-B04A-BBC692C2DBF3 @default.
- Q71931319 P356 Q71931319-75957D50-BCF5-43C3-AB16-BEC13291D315 @default.
- Q71931319 P433 Q71931319-131230D4-BDDC-4AF0-B2EC-28BACDD9F12A @default.
- Q71931319 P478 Q71931319-E0CDB4C6-40A8-4580-80D1-AAF7FEA0888C @default.
- Q71931319 P577 Q71931319-EEE75D3A-641B-4932-848C-473732CB2164 @default.
- Q71931319 P698 Q71931319-02FD363A-61F5-4558-B6FB-B838BD9508A0 @default.
- Q71931319 P921 Q71931319-8308A76A-80D2-49C9-B262-452CDBD9D0E6 @default.
- Q71931319 P921 Q71931319-DEA51349-46AD-4E4D-9267-0FA3FECF3AE1 @default.
- Q71931319 P921 Q71931319-E1D0B0CE-7555-4834-95D6-AF334B4E3BBC @default.
- Q71931319 P356 (SICI)1097-0045(199612)29:6%3C371::AID-PROS5%3E3.0.CO;2-B @default.
- Q71931319 P698 8977634 @default.
- Q71931319 P1433 Q7758608 @default.
- Q71931319 P1476 "Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen" @default.
- Q71931319 P2093 "Boynton A" @default.
- Q71931319 P2093 "Kenny G" @default.
- Q71931319 P2093 "Murphy G" @default.
- Q71931319 P2093 "Ragde H" @default.
- Q71931319 P2093 "Tjoa B" @default.
- Q71931319 P304 "371-380" @default.
- Q71931319 P31 Q13442814 @default.
- Q71931319 P356 "10.1002/(SICI)1097-0045(199612)29:6<371::AID-PROS5>3.0.CO;2-B" @default.
- Q71931319 P433 "6" @default.
- Q71931319 P478 "29" @default.
- Q71931319 P577 "1996-12-01T00:00:00Z" @default.
- Q71931319 P698 "8977634" @default.
- Q71931319 P921 Q181257 @default.
- Q71931319 P921 Q506253 @default.
- Q71931319 P921 Q5452194 @default.